Amanote Research
Register
Sign In
Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery
doi 10.1021/acsami.6b16844.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Telodendrimer Nanocarrier for Co-Delivery of Paclitaxel and Cisplatin: A Synergistic Combination Nanotherapy for Ovarian Cancer Treatment
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity
Journal of Pharmaceutical Sciences
Pharmaceutical Science
Comparison of the Efficacy Between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer
Cancer Research and Treatment
Cancer Research
Oncology
In Vivo Evaluation of Doxorubicin-Loaded Polymeric Micelles Targeting Folate Receptors and Early Endosomal pH in Drug-Resistant Ovarian Cancer
Molecular Pharmaceutics
Drug Discovery
Molecular Medicine
Pharmaceutical Science
Combination Chemotherapy for Advanced Urothelial Cancer With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-Vac)
Japanese Journal of Urology
Urology
Mixed pH-Sensitive Polymeric Micelles for Combination Drug Delivery
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Novel Polymer Micelle Mediated Co-Delivery of Doxorubicin and P-Glycoprotein siRNA for Reversal of Multidrug Resistance and Synergistic Tumor Therapy
Scientific Reports
Multidisciplinary
Phosphorylcholine Oligomer-Grafted Graphene Oxide for Tumor-Targeting Doxorubicin Delivery
RSC Advances
Chemistry
Chemical Engineering
Role of Combination Chemotherapy With 5-Fluorouracil, Cisplatin and Paclitaxel for Advanced Gall Bladder Cancer
Journal of Cancer Therapy
